Effects of self-guided digital cognitive behavioural therapy on symptoms of generalized anxiety disorder and related disorders: a randomised controlled trial

niversity of Oxford0 sites224 target enrollmentMay 27, 2021

Overview

No summary available.

Registry

who.int

Start Date

May 27, 2021

End Date

March 14, 2023

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•1\. Adults aged \=18 years old
•2\. Score \=10 on the 7\-item Generalized Anxiety Disorder scale (GAD\-7\)
•3\. Screen positive for GAD diagnosis against Diagnostic and Statistical Manual of Mental Disorders (DSM\-5\) criteria and phone call verification of diagnosis using a modified version of the Structured Clinical Interview for DSM\-5 (SCID)
•4\. Either not on psychotropic medication or on a stable dose for at least 4 weeks before screening assessment
•5\. Oral and written fluency in English
•6\. Participant is able and willing to comply with protocol requirements, has been informed of the nature of the study, and has signed the approved informed consent form

•1\. Currently receiving or be expecting to start CBT for anxiety during study participation, or have previously received CBT for anxiety in the past 12\-months (self\-report)
•2\. Self\-reported diagnosis of schizophrenia, psychosis, bipolar disorder, seizure disorder, substance use disorder; recent trauma to the head or brain damage; recent inpatient psychiatric admission or crisis team support
•3\. Cognitive impairment that does not allow participants to consent or follow treatment instructions (self\-report)
•4\. Physical health concerns necessitating surgery or with \<6 months to live (self\-report)
•5\. Hearing or vision impairment that prevents effective use of the audio\-visual content of digital CBT